Language selection

Search


Tradename information - 7411000087108

View tradename immunizing agents subset

Concept details

[LZV] ZOSTAVAX


Pan-Canadian SNOMED CT terminology

Concept code
7411000087108
Concept status
active
Version
20250531
Display name
English: [LZV] ZOSTAVAX
French: [VVVCZ] ZOSTAVAX
Abbreviation
English: LZV
French: VVVCZ
Patient Picklist
English: ZOSTAVAX
French: ZOSTAVAX
Fully specified name
ZOSTAVAX 19400 plaque forming units per 0.65 milliliter powder and diluent for suspension for injection Merck Canada Inc. (real clinical drug)
Market authorization holder
MERCK CANADA INC.

Health Canada Drug Information

Drug Identification Number Product status Strength Typical dose External Links
02315939 Cancelled Post Market See product monograph 0.65 ML

Linked product data

Lot numbers
  • not available

Linked concepts

Linked Immunization Route(s) of Administration

This vaccine protects against the following diseases:

This vaccine contains the following antigens:


National Vaccine Catalogue database details

Last updated
2025-08-11

Concept history

This concept replaces

Market Authorization Holder Concept History
Concept code Display name
No data is available

Notice

Some information normally contained in the National Vaccine Catalogue may be unavailable due to ongoing mapping updates or because the source data did not provide the information, and in some cases, the information field is blank as it may not be applicable in the given context. The information contained in the National Vaccine Catalogue may also be subject to change following data reconciliation.

Disclaimer

The use of the standard SNOMED CT terminology and codes is subject to your annual acceptance of both the SNOMED CT® Affiliate License Agreement and the SNOMED CT® Canadian National License Agreement. To acknowledge and accept these agreements, register an account on Canada Health Infoway. For additional information on the agreements, please visit Canada Health Infoway.

Version:
1.6.0